Blood pressure lowering is associated with reduced risk of death and cardiovascular disease in patients with baseline SBP of 140 mm Hg or higher.
Does blood pressure lowering reduce death and CVD across different baseline blood pressure levels in primary prevention and CHD patients?
Blood pressure lowering for primary prevention is beneficial when baseline SBP is ≥140 mm Hg, while patients with established CHD may benefit from treatment at lower BP levels.
Absolute Event Rate: 0% vs 0%
Primary preventive BP lowering is associated with reduced risk for death and CVD if baseline SBP is 140 mm Hg or higher. At lower BP levels, treatment is not associated with any benefit in primary prevention but might offer additional protection in patients with CHD.
Brunström et al. (Mon,) reported a other. Blood pressure lowering is associated with reduced risk of death and cardiovascular disease in patients with baseline SBP of 140 mm Hg or higher.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: